SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PharmaEssentia to Present Preclinical Pipeline Data at SITC Meeting

The company says two posters will highlight preclinical data for PEC 2001 and 3001, including a myeloid checkpoint inhibitor.

Related stories